The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CBDS | +129.67% | -92.79% | -40.87% | -96% |
| S&P | +16.9% | +95.99% | +14.39% | +315% |
Cannabis Sativa, Inc. engages in the telemedicine business while seeking opportunities in brand development and marketing of products and services to the cannabidiol and marijuana industries. Its Telemedicine, PrestoCorp offers an online telemedicine platform providing customers with access to knowledgeable physicians to obtain a medical marijuana recommendation. The company was founded on November 5, 2005 and is headquartered in Mesquite, NV.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.19M | -17.9% |
| Gross Profit | $0.05M | -14.8% |
| Gross Margin | 23.46% | 0.9% |
| Market Cap | $4.21M | 195.1% |
| Market Cap / Employee | $0.60M | 0.0% |
| Employees | 7 | 0.0% |
| Net Income | -$7.30M | -1766.9% |
| EBITDA | -$0.18M | 7.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $0.05M | -16.9% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | 0.0% |
| Short Term Debt | $0.56M | -6.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -73.15% | -17.9% |
| Return On Invested Capital | 110.49% | 36950.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $0.00M | 100.5% |
| Operating Free Cash Flow | $0.00M | 100.5% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -0.51 | -8.03 | -3.77 | -2.72 | 75.57% |
| Price to Sales | 0.62 | 12.03 | 7.70 | 5.88 | 329.60% |
| Price to Tangible Book Value | -0.19 | -3.22 | -1.51 | -1.49 | 209.10% |
| Enterprise Value to EBITDA | -13.27 | -80.64 | -72.76 | -31.31 | 95.84% |
| Total Debt | $0.60M | $0.54M | $0.55M | $0.56M | -6.79% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
